An overview of the efficacy of inhaled curcumin: a new mode of administration for an old molecule

REFERENCES

• Govindarajan V, Stahl WH. Turmeric—chemistry, technology, and quality. Crit Rev Food Sci Nutr. 1980;12(3):199–301. doi: 10.1080/10408398009527278
   PubMed Web of Science ®Google Scholar
• Chattopadhyay I, Biswas K, Bandyopadhyay U, Banerjee RK. Turmeric and curcumin: Biological actions and medicinal applications. Curr Sci. 2004:44–53.
   Web of Science ®Google Scholar
• Lestari ML, Indrayanto G. Curcumin. Profiles of drug substances, excipients and related methodology. 2014;39:113–204.
   Google Scholar
• Rafiee Z, Nejatian M, Daeihamed M, et al. Application of curcumin-loaded nanocarriers for food, drug and cosmetic purposes. Trends Food Sci Technol. 2019;88:445–458.10.1016/j.tifs.2019.04.017
   Web of Science ®Google Scholar
• Marjaneh RM, Rahmani F, Hassanian SM, Rezaei N, Hashemzehi M, Bahrami A, et al. Phytosomal curcumin inhibits tumor growth in colitis‐associated colorectal cancer. Journal of cellular physiology. 2018;233(10):6785–98.
   PubMed Web of Science ®Google Scholar
• Keihanian F, Saeidinia A, Bagheri RK, Johnston TP, Sahebkar A. Curcumin, hemostasis, thrombosis, and coagulation. Journal of cellular physiology. 2018;233(6):4497–511.
   PubMed Web of Science ®Google Scholar
• Cicero AF, Sahebkar A, Fogacci F, Bove M, Giovannini M, Borghi C. Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: A double-blind, placebo-controlled clinical trial. European Journal of Nutrition. 2020;59:477–83.
   PubMed Web of Science ®Google Scholar
• Mokhtari‐Zaer A, Marefati N, Atkin SL, Butler AE, Sahebkar A. The protective role of curcumin in myocardial ischemia–reperfusion injury. Journal of cellular physiology. 2019;234(1):214–22.
   Web of Science ®Google Scholar
• Mohammadi A, Blesso CN, Barreto GE, et al. Macrophage plasticity, polarization and function in response to curcumin, a diet-derived polyphenol, as an immunomodulatory agent. J Nutr Biochem. 2019;66:1–16.10.1016/j.jnutbio.2018.12.005
   PubMed Web of Science ®Google Scholar
• Khayatan D, Razavi SM, Arab ZN, et al. Protective effects of curcumin against traumatic brain injury. Biomed Pharmacother. 2022;154:113621.10.1016/j.biopha.2022.113621
   PubMed Web of Science ®Google Scholar
• Panahi Y, Fazlolahzadeh O, Atkin SL, Majeed M, Butler AE, Johnston TP, et al. Evidence of curcumin and curcumin analogue effects in skin diseases: A narrative review. Journal of cellular physiology. 2019;234(2):1165–78.
   PubMed Web of Science ®Google Scholar
• Mohajeri M, Sahebkar A. Protective effects of curcumin against doxorubicin-induced toxicity and resistance: A review. Critical reviews in oncology/hematology. 2018;122:30–51.10.1016/j.critrevonc.2017.12.005
   PubMed Web of Science ®Google Scholar
• Heidari H, Bagherniya M, Majeed M, et al. Curcumin-piperine co-supplementation and human health: a comprehensive review of preclinical and clinical studies. Phytother Res. 2023;37(4):1462–1487. doi: 10.1002/ptr.7737
   PubMed Web of Science ®Google Scholar
• Ahmadi A, Jamialahmadi T, Sahebkar A. Polyphenols and atherosclerosis: A critical review of clinical effects on LDL oxidation. Pharmacological Research. 2022;184. 184 10.1016/j.phrs.2022.106414
   Web of Science ®Google Scholar
• Joe B, Vijaykumar M, Lokesh B. Biological properties of curcumin-cellular and molecular mechanisms of action. Critical reviews in food science and nutrition. Crit Rev Food Sci Nutr. 2004;44(2):97–111. doi: 10.1080/10408690490424702
   PubMed Web of Science ®Google Scholar
• Bagheri H, Ghasemi F, Barreto GE, et al. Effects of curcumin on mitochondria in neurodegenerative diseases. BioFactors. 2020;46(1):5–20. doi: 10.1002/biof.1566
   PubMed Web of Science ®Google Scholar
• Iranshahi M, Sahebkar A, Hosseini ST, et al. Cancer chemopreventive activity of diversin from Ferula diversivittata in vitro and in vivo. Phytomedicine. 2010;17(3–4):269–273. doi: 10.1016/j.phymed.2009.05.020
   PubMed Web of Science ®Google Scholar
• Rezaee R, Momtazi AA, Monemi A, Sahebkar A. Curcumin: A potentially powerful tool to reverse cisplatin-induced toxicity. Pharmacological Research. 2017;117:218–27.
   PubMed Web of Science ®Google Scholar
• Sahebkar A. Curcuminoids for the management of hypertriglyceridaemia. Nat Rev Cardiol. 2014;11(2):123–123. doi: 10.1038/nrcardio.2013.140-c1
   PubMed Web of Science ®Google Scholar
• Soltani S, Boozari M, Cicero AFG, et al. Effects of phytochemicals on macrophage cholesterol efflux capacity: impact on atherosclerosis. Phytother Res. 2021;35(6):2854–2878. doi: 10.1002/ptr.6991
   PubMed Web of Science ®Google Scholar
• Zahedi M, Izadi HS, Arghidash F, Gumpricht E, Banach M, Sahebkar A. The effect of curcumin on hypoxia in the tumour microenvironment as a regulatory factor in cancer. Arch Med Sci. 2023;19(6):1616–29.
   PubMed Web of Science ®Google Scholar
• Fereydouni N, Darroudi M, Movaffagh J, Shahroodi A, Butler AE, Ganjali S, et al. Curcumin nanofibers for the purpose of wound healing. Journal of Cellular Physiology. 2019;234(5):5537–54.
   PubMed Web of Science ®Google Scholar
• Zorofchian Moghadamtousi S, Abdul Kadir H, Hassandarvish P, Tajik H, Abubakar S, Zandi K. A review on antibacterial, antiviral, and antifungal activity of curcumin. BioMed research international. 2014; 2014.
   Web of Science ®Google Scholar
• da Silva AC, de Freitas Santos PD, do Prado Silva JT, Leimann FV, Bracht L, Goncalves OH. Impact of curcumin nanoformulation on its antimicrobial activity. Trends in Food Science & Technology. 2018;72:74–82.
   Web of Science ®Google Scholar
• Akbik D, Ghadiri M, Chrzanowski W, et al. Curcumin as a wound healing agent. Life Sci. 2014;116(1):1–7. doi: 10.1016/j.lfs.2014.08.016
   PubMed Web of Science ®Google Scholar
• Rivera-Mancía S, Trujillo J, Chaverri JP. Utility of curcumin for the treatment of diabetes mellitus: evidence from preclinical and clinical studies. Journal of Nutrition & Intermediary Metabolism. 2018;14:29–41.10.1016/j.jnim.2018.05.001
   Google Scholar
• Memarzia A, Khazdair MR, Behrouz S, et al. Experimental and clinical reports on anti-inflammatory, antioxidant, and immunomodulatory effects of curcuma longa and curcumin, an updated and comprehensive review. BioFactors. 2021;47(3):311–350. doi: 10.1002/biof.1716
   PubMed Web of Science ®Google Scholar
• Kahkhaie KR, Mirhosseini A, Aliabadi A, Mohammadi A, Mousavi MJ, Haftcheshmeh SM, et al.. Curcumin: a modulator of inflammatory signaling pathways in the immune system. Inflammopharmacology. 2019;27(5):885–900. doi: 10.1007/s10787-019-00607-3
   PubMed Web of Science ®Google Scholar
• Panahi Y, Sahebkar A, Amiri M, et al. Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial. British Journal Of Nutrition. 2012;108(7):1272–1279. doi: 10.1017/S0007114511006544
   PubMed Web of Science ®Google Scholar
• Shafabakhsh R, Pourhanifeh MH, Mirzaei HR, Sahebkar A, Asemi Z, Mirzaei H. Targeting regulatory T cells by curcumin: A potential for cancer immunotherapy. Pharmacological Research. 2019;147. 147 10.1016/j.phrs.2019.104353
   Web of Science ®Google Scholar
• Menon VP, Sudheer AR. Antioxidant and anti-inflammatory properties of curcumin. The molecular targets and therapeutic uses of curcumin in health and disease. 2007:105–25.
   Google Scholar
• Shishodia S, Amin HM, Lai R, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol. 2005;70(5):700–13.
   PubMed Web of Science ®Google Scholar
• Nasir Abbas Bukhari S, Jantan I. Synthetic curcumin analogs as inhibitors of β-amyloid peptide aggregation: potential therapeutic and diagnostic agents for Alzheimer’s disease. Mini reviews in medicinal chemistry. 2015;15(13):1110–21.
   PubMed Web of Science ®Google Scholar
• Sharma RK, Cwiklinski K, Aalinkeel R, Reynolds JL, Sykes DE, Quaye E, et al.. Immunomodulatory activities of curcumin-stabilized silver nanoparticles: Efficacy as an antiretroviral therapeutic. Immunological investigations. 2017;46(8):833–846. doi: 10.1080/08820139.2017.1371908
   PubMed Web of Science ®Google Scholar
• Yu F, Zhang Y, Yang C, et al. Enhanced transdermal efficiency of curcumin-loaded peptide-modified liposomes for highly effective antipsoriatic therapy. J Mat Chem B. 2021;9(24):4846–4856. doi: 10.1039/D1TB00557J
   PubMed Web of Science ®Google Scholar
• Bosman B. Testing of lipoxygenase inhibitors, cyclooxygenase inhibitors, drugs with immunomodulating properties and some reference antipsoriatic drugs in the modified mouse tail test, an animal model of psoriasis. Skin Pharmacol Physiol. 1994;7(6):324–334. doi: 10.1159/000211314
   Google Scholar
• Rahimi HR, Nedaeinia R, Sepehri Shamloo A, Nikdoust S, Kazemi Oskuee R. Novel delivery system for natural products: Nano-curcumin formulations. Avicenna J Phytomed. 2016;6(4):383–398.
   PubMed Web of Science ®Google Scholar
• Nelson KM, Dahlin JL, Bisson J, et al. The essential medicinal chemistry of curcumin: miniperspective. J Med Chem. 2017;60(5):1620–1637. doi: 10.1021/acs.jmedchem.6b00975
   PubMed Web of Science ®Google Scholar
• Hu L, Kong D, Hu Q, Gao N, Pang S. Evaluation of high-performance curcumin nanocrystals for pulmonary drug delivery both in vitro and in vivo. Nanoscale research letters. 2015;10:1–9.
   PubMed Web of Science ®Google Scholar
• El-Sherbiny IM, Smyth HD. Controlled release pulmonary administration of curcumin using swellable biocompatible microparticles. Mol Pharmaceut. 2012;9(2):269–80.
   PubMed Web of Science ®Google Scholar
• Bhawana, Basniwal RK, Buttar HS, Jain V, Jain N. Curcumin nanoparticles: preparation, characterization, and antimicrobial study. J Agric Food Chemistry. 2011;59(5):2056–61.
   PubMed Web of Science ®Google Scholar
• Hanafy NA, Sheashaa RF, Moussa EA, Mahfouz ME. Potential of curcumin and niacin-loaded targeted chitosan coated liposomes to activate autophagy in hepatocellular carcinoma cells: An in vitro evaluation in HePG2 cell line. Int j biol macromol. 2023;245:125572.
   PubMed Web of Science ®Google Scholar
• Hanafy NA, Leporatti S, El-Kemary MA. Mucoadhesive hydrogel nanoparticles as smart biomedical drug delivery system. Appl Sci. 2019;9(5):825. doi: 10.3390/app9050825
   Google Scholar
• Kurita T, Makino Y. Novel curcumin oral delivery systems. Anticancer Res. 2013;33(7):2807–2821.
   PubMed Web of Science ®Google Scholar
• Ravichandran R. Pharmacokinetic study of nanoparticulate curcumin: oral formulation for enhanced bioavailability. Journal of Biomaterials and Nanobiotechnology. 2013;04(03):291–299. doi: 10.4236/jbnb.2013.43037
   Google Scholar
• Choi YH, Han H-K. Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics. J Pharm Invest. 2018;48(1):43–60. doi: 10.1007/s40005-017-0370-4
   PubMedGoogle Scholar
• Bonifacio BV, da Silva PB, Ramos MAdS, Negri KMS, Bauab TM, Chorilli M. Nanotechnology-based drug delivery systems and herbal medicines: a review. International journal of nanomedicine. 2014:1–15.
   PubMedGoogle Scholar
• Muhamad N, Plengsuriyakarn T, Na-Bangchang K Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review. Int j nanomed. 2018:3921–3935. Volume 13 10.2147/IJN.S165210
   Web of Science ®Google Scholar
• Chaturvedi N, Solanki H. Pulmonary drug delivery system: review. Int J Appl Pharm. 2013;5(3):7–10.
   Google Scholar
• Chaurasiya B, Zhao Y-Y. Dry powder for pulmonary delivery: a comprehensive review. Pharmaceutics. 2021;13(1):31.
   Web of Science ®Google Scholar
• Kurniawansyah F, Duong HT, Luu TD, Mammucari R, Vittorio O, Boyer C, et al. Inhalable curcumin formulations: Micronization and bioassay. Chem Eng J. 2015;279:799–808.
   Web of Science ®Google Scholar
• Kurniawansyah F, Mammucari R, Foster NR Inhalable curcumin formulations by supercritical technology. Powder Technol. 2015;284:289–298.10.1016/j.powtec.2015.04.083
   Web of Science ®Google Scholar
• Torre LA, Siegel RL, Jemal A. Lung cancer statistics. Lung cancer and personalized medicine. 2016:1–19.
   Google Scholar
• Thai AA, Solomon BJ, Sequist LV, et al. Lung cancer. Lancet. 2021;398(10299):535–554. doi: 10.1016/S0140-6736(21)00312-3
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca A Cancer J Clinicians. 2021;71(3):209–249. doi: 10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Hafez Ghoran S, Calcaterra A, Abbasi M, Taktaz F, Nieselt K, Babaei E. Curcumin-based nanoformulations: A promising adjuvant towards cancer treatment. Molecules. 2022;27(16):5236. doi: 10.3390/molecules27165236
   PubMed Web of Science ®Google Scholar
• Cristiano MC, Froiio F, Spaccapelo R, Mancuso A, Nisticò SP, Udongo BP, et al.. Sulforaphane-loaded ultradeformable vesicles as a potential natural nanomedicine for the treatment of skin cancer diseases. Pharmaceutics. 2019;12(1):6. doi: 10.3390/pharmaceutics12010006
   PubMed Web of Science ®Google Scholar
• Mansouri K, Rasoulpoor S, Daneshkhah A, et al. Clinical effects of curcumin in enhancing cancer therapy: a systematic review. BMC Cancer. 2020;20(1):1–11. doi: 10.1186/s12885-020-07256-8
   Web of Science ®Google Scholar
• Bachmeier BE, Killian PH, Melchart D. The role of curcumin in prevention and management of metastatic disease. Int J Mol Sci. 2018;19(6):1716. doi: 10.3390/ijms19061716
   PubMed Web of Science ®Google Scholar
• Islam MR, Islam F, Nafady MH, Akter M, Mitra S, Das R, et al.. Natural small molecules in breast cancer treatment: understandings from a therapeutic viewpoint. Molecules. 2022;27(7):2165. doi: 10.3390/molecules27072165
   PubMed Web of Science ®Google Scholar
• Hanafi-Bojd MY, Jaafari MR, Ramezanian N, et al. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells. Eur J Pharm Biopharm. 2015;89:248–258.10.1016/j.ejpb.2014.12.009
   PubMed Web of Science ®Google Scholar
• Hanafi-Bojd MY, Moosavian Kalat SA, Taghdisi SM, Ansari L, Abnous K, Malaekeh-Nikouei B. MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells. Drug development and industrial pharmacy. 2018;44(1):13–18. doi: 10.1080/03639045.2017.1371734
   PubMed Web of Science ®Google Scholar
• Rastegari E, Hsiao Y-J, Lai W-Y, Lai Y-H, Yang T-C, Chen S-J, et al.. An update on mesoporous silica nanoparticle applications in nanomedicine. Pharmaceutics. 2021;13(7):1067. doi: 10.3390/pharmaceutics13071067
   PubMed Web of Science ®Google Scholar
• Bharti C, Nagaich U, Pal AK, Gulati N. Mesoporous silica nanoparticles in target drug delivery system: A review. Int j pharm invest. 2015;5(3):124.
   PubMed Web of Science ®Google Scholar
• Tomer VK, Malik R, Jangra S, et al. One pot direct synthesis of mesoporous SnO2/SBA-15 nanocomposite by the hydrothermal method. Materials Letters. 2014;132:228–230.10.1016/j.matlet.2014.06.088
   Web of Science ®Google Scholar
• Szegedi A, Popova M, Goshev I, et al. Effect of amine functionalization of spherical MCM-41 and SBA-15 on controlled drug release. J Solid State Chem. 2011;184(5):1201–1207. doi: 10.1016/j.jssc.2011.03.005
   Web of Science ®Google Scholar
• Tingming F, Liwei G, Kang L, et al. Template occluded SBA-15: an effective dissolution enhancer for poorly water-soluble drug. Appl Surface Sci. 2010;256(23):6963–6968. doi: 10.1016/j.apsusc.2010.05.007
   Web of Science ®Google Scholar
• Zhang Y, Zhi Z, Jiang T, et al. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan. JControlled Release. 2010;145(3):257–263. doi: 10.1016/j.jconrel.2010.04.029
   PubMed Web of Science ®Google Scholar
• Su W, Wei T, Lu M, et al. Treatment of metastatic lung cancer via inhalation administration of curcumin composite particles based on mesoporous silica. Eur J Pharmaceut Sci. 2019;134:246–255. doi: 10.1016/j.ejps.2019.04.025.
   PubMed Web of Science ®Google Scholar
• Wu Q, Ou H, Shang Y, et al. Nanoscale formulations: incorporating curcumin into combination strategies for the treatment of lung cancer. Drug design develop therapy. 2021:2695–2709. Volume 15 10.2147/DDDT.S311107
   Web of Science ®Google Scholar
• Zhang T, Chen Y, Ge Y, et al. Inhalation treatment of primary lung cancer using liposomal curcumin dry powder inhalers. Acta Pharm Sin B. 2018;8(3):440–448. 10.1016/j.apsb.2018.03.004
   PubMed Web of Science ®Google Scholar
• Adel IM, ElMeligy MF, Abdelrahim ME, et al. Design and characterization of spray-dried proliposomes for the pulmonary delivery of curcumin. Int j nanomed. 2021:2667–2687. Volume 16 10.2147/IJN.S306831
   Web of Science ®Google Scholar
• Elmowafy M, Shalaby K, Elkomy MH, Alsaidan OA, Gomaa HA, Abdelgawad MA, et al. Polymeric Nanoparticles for Delivery of Natural Bioactive Agents: Recent Advances and Challenges. Polymers. 2023;15(5):1123.
   PubMed Web of Science ®Google Scholar
• Dobrzyńska I, Skrzydlewska E, Figaszewski ZA. Changes in electric properties of human breast cancer cells. J Membr Biol. 2013;246(2):161–166. doi: 10.1007/s00232-012-9516-5
   PubMed Web of Science ®Google Scholar
• Jyoti K, Pandey RS, Madan J, Jain UK. Inhalable cationic niosomes of curcumin enhanced drug delivery and apoptosis in lung cancer cells. Indian J Pharm Educ Res. 2016;50(2s):S21–31.
   Google Scholar
• Loo C-Y, Traini D, Young PM, et al. Pulmonary delivery of curcumin and quercetin nanoparticles for lung cancer–Part 1: Aerosol performance characterization. J Drug Delivery Sci Technol. 2023;86:104646.10.1016/j.jddst.2023.104646
   Web of Science ®Google Scholar
• Loo C-Y, Traini D, Young PM, et al. Pulmonary delivery of curcumin and quercetin nanoparticles for lung cancer–Part 2: Toxicity and endocytosis. J Drug Delivery Sci Technol. 2023;82:104375.10.1016/j.jddst.2023.104375
   Web of Science ®Google Scholar
• Dewangan AK, Perumal Y, Pavurala N, et al. Preparation, characterization and anti-inflammatory effects of curcumin loaded carboxymethyl cellulose acetate butyrate nanoparticles on adjuvant induced arthritis in rats. J Drug Delivery Sci Technol. 2017;41:269–279.10.1016/j.jddst.2017.07.022
   Web of Science ®Google Scholar
• Gan Y, Zheng S, Baak JP, Zhao S, Zheng Y, Luo N, et al. Prediction of the anti-inflammatory mechanisms of curcumin by module-based protein interaction network analysis. Acta Pharm Sin B. 2015;5(6):590–5.
   PubMed Web of Science ®Google Scholar
• Priyanka A, Shyni G, Anupama N, et al. Development of insulin resistance through sprouting of inflammatory markers during hypoxia in 3T3-L1 adipocytes and amelioration with curcumin. Eur J Pharmacol. 2017;812:73–81.10.1016/j.ejphar.2017.07.005
   PubMed Web of Science ®Google Scholar
• Seyedzadeh MH, Safari Z, Zare A, Navashenaq JG, Kardar GA, Khorramizadeh MR. Study of curcumin immunomodulatory effects on reactive astrocyte cell function. International immunopharmacology. 2014;22(1):230–5.
   PubMed Web of Science ®Google Scholar
• Lelli D, Sahebkar A, Johnston TP, Pedone C. Curcumin use in pulmonary diseases: State of the art and future perspectives. Pharmacological research. 2017;115:133–148.10.1016/j.phrs.2016.11.017
   PubMed Web of Science ®Google Scholar
• Chen J, He Z-M, Wang F-L, Zhang Z-S, Liu X-z, Zhai D-D, et al. Curcumin and its promise as an anticancer drug: An analysis of its anticancer and antifungal effects in cancer and associated complications from invasive fungal infections. Eur J Pharmacol. 2016;772:33–42.
   PubMed Web of Science ®Google Scholar
• Jaroonwitchawan T, Chaicharoenaudomrung N, Namkaew J, et al. Curcumin attenuates paraquat-induced cell death in human neuroblastoma cells through modulating oxidative stress and autophagy. Neurosci lett. 2017;636:40–47.10.1016/j.neulet.2016.10.050
   PubMed Web of Science ®Google Scholar
• Resnik R. Intrauterine growth restriction12 1We would like to thank the following individuals who, in addition to members of our Editorial Board, will serve as referees for this series: Dwight P. Cruikshank, MD, Ronald S. Gibbs, MD, Gary D. V. Hankins, MD, Philip B. Mead, MD, Kenneth L. Noller, MD, Catherine Y. Spong, MD, and Edward E. Wallach, MD. 2We have invited select authorities to present background information on challenging clinical problems and practical information on diagnosis and treatment for use by practitioners. Obstetrics & Gynecology. 2002;99(3):490–6.
   PubMed Web of Science ®Google Scholar
• Guillier C, Carrière D, Pansiot J, Maroni A, Billion E, Ringot M, et al. Nebulized curcumin protects neonatal lungs from antenatal insult in rats. Am J Physiol Lung Cell Mol Physiol. 2021;321(3):L545–L52.
   PubMed Web of Science ®Google Scholar
• Gao J, Huang Y, Li P, Xu D, Li J, Liu Y, et al.. Antifibrosis effects of total glucosides of Danggui–Buxue–Tang in a rat model of bleomycin-induced pulmonary fibrosis. Journal of Ethnopharmacology. 2011;136(1):21–26. doi: 10.1016/j.jep.2011.03.013
   PubMed Web of Science ®Google Scholar
• Hemmati AA, Karampour NS, Dahanzadeh S, et al. The protective effects of nebulized nano-curcumin against bleomycin-induced pulmonary fibrosis in rats. Jundishapur J Nat Pharm Prod. 2021;16(2). doi: 10.5812/jjnpp.106961
   Web of Science ®Google Scholar
• Yang Y, Bajaj N, Xu P, et al. Development of highly porous large PLGA microparticles for pulmonary drug delivery. Biomaterials. 2009;30(10):1947–1953. doi: 10.1016/j.biomaterials.2008.12.044
   PubMed Web of Science ®Google Scholar
• Zhu L, Li M, Liu X, et al. Inhalable oridonin-loaded poly (lactic-co-glycolic) acid large porous microparticles for in situ treatment of primary non-small cell lung cancer. Acta Pharm Sin B. 2017;7(1):80–90. doi: 10.1016/j.apsb.2016.09.006
   PubMed Web of Science ®Google Scholar
• Hu Y, Li M, Zhang M, et al. Inhalation treatment of idiopathic pulmonary fibrosis with curcumin large porous microparticles. Int J Pharmaceut. 2018;551(1–2):212–222. 10.1016/j.ijpharm.2018.09.031
   PubMed Web of Science ®Google Scholar
• Chang W-A, Chen C-M, Sheu C-C, Liao S-H, Hsu Y-L, Tsai M-J, et al. The Potential Effects of Curcumin on Pulmonary Fibroblasts of Idiopathic Pulmonary Fibrosis (IPF)—Approaching with Next-Generation Sequencing and Bioinformatics. Molecules [Internet]. 2020; 25(22). 5458 10.3390/molecules25225458
   PubMed Web of Science ®Google Scholar
• Tsoutsou PG, Koukourakis MI. Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research. Int J Radiat Oncol Biol Phys. 2006;66(5):1281–1293. doi: 10.1016/j.ijrobp.2006.08.058
   PubMed Web of Science ®Google Scholar
• Simone II CB, editor Thoracic radiation normal tissue injury. Seminars in radiation oncology; 2017: Elsevier.
   Google Scholar
• Farhood B, Mortezaee K, Goradel NH, Khanlarkhani N, Salehi E, Nashtaei MS, et al. Curcumin as an anti‐inflammatory agent: Implications to radiotherapy and chemotherapy. Journal of cellular physiology. 2019;234(5):5728–40.
   PubMed Web of Science ®Google Scholar
• Yang MY, Chan JGY, Chan H-K Pulmonary drug delivery by powder aerosols. JControlled Release. 2014;193:228–240.10.1016/j.jconrel.2014.04.055
   PubMed Web of Science ®Google Scholar
• Woo MW, Mansouri S, Chen XD. Antisolvent vapor precipitation: the future of pulmonary drug delivery particle production? Expert Opin Drug Delivery. 2014;11(3):307–311. doi: 10.1517/17425247.2014.875527
   PubMed Web of Science ®Google Scholar
• Matthay MA, Zemans RL. The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol. 2011;6(1):147–163. doi: 10.1146/annurev-pathol-011110-130158
   PubMedGoogle Scholar
• Beck-Broichsitter M, Merkel OM, Kissel T. Controlled pulmonary drug and gene delivery using polymeric nano-carriers. JControlled Release. 2012;161(2):214–224. doi: 10.1016/j.jconrel.2011.12.004
   PubMed Web of Science ®Google Scholar
• Zupancic S, Kocbek P, Zariwala MG, Renshaw D, Gul MO, Elsaid Z, et al. Design and development of novel mitochondrial targeted nanocarriers, DQAsomes for curcumin inhalation. Mol Pharmaceut. 2014;11(7):2334–45.
   PubMed Web of Science ®Google Scholar
• Inapagolla R, Guru BR, Kurtoglu Y, et al. In vivo efficacy of dendrimer–methylprednisolone conjugate formulation for the treatment of lung inflammation. Int J Pharmaceut. 2010;399(1–2):140–147. doi: 10.1016/j.ijpharm.2010.07.030
   PubMed Web of Science ®Google Scholar
• Wang W, Zhu R, Xie Q, Li A, Xiao Y, Li K, et al. Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles. Int j nanomed. 2012:3667–77.
   PubMed Web of Science ®Google Scholar
• Forbes B, Asgharian B, Dailey LA, et al. Challenges in inhaled product development and opportunities for open innovation. Adv Drug Delivery Rev. 2011;63(1–2):69–87. doi: 10.1016/j.addr.2010.11.004
   PubMed Web of Science ®Google Scholar
• Onoue S, Aoki Y, Kawabata Y, et al. Development of inhalable nanocrystalline solid dispersion of tranilast for airway inflammatory diseases. J Pharmaceut sci. 2011;100(2):622–633. doi: 10.1002/jps.22299
   PubMed Web of Science ®Google Scholar
• Hu X, Yang F-F, Wei X-L, Yao G-Y, Liu C-Y, Zheng Y, et al. Curcumin acetate nanocrystals for sustained pulmonary delivery: preparation, characterization and in vivo evaluation. Journal of Biomedical Nanotechnology. 2017;13(1):99–109.
   PubMed Web of Science ®Google Scholar
• Goedert M, Spillantini MG. A century of Alzheimer’s disease. Science. 2006;314(5800):777–781. doi: 10.1126/science.1132814
   PubMed Web of Science ®Google Scholar
• Abubakar MB, Sanusi KO, Ugusman A, Mohamed W, Kamal H, Ibrahim NH, et al. Alzheimer’s disease: An update and insights into pathophysiology. Frontiers in Aging Neuroscience. 2022;14:742408.
   PubMed Web of Science ®Google Scholar
• Shabbir U, Rubab M, Tyagi A, Oh D-H. Curcumin and its derivatives as theranostic agents in Alzheimer’s disease: The implication of nanotechnology. Int J Mol Sci. 2020;22(1):196.
   PubMed Web of Science ®Google Scholar
• Lv H, Wang Y, Yang X, Ling G, Zhang P. Application of curcumin nanoformulations in Alzheimer’s disease: prevention, diagnosis and treatment. Nutritional Neuroscience. 2023;26(8):727–742. doi: 10.1080/1028415X.2022.2084550
   PubMed Web of Science ®Google Scholar
• Ahmad N, Ahmad R, Alrasheed RA, Almatar HMA, Al-Ramadan AS, Amir M, et al.. Quantification and evaluations of catechin hydrate polymeric nanoparticles used in brain targeting for the treatment of epilepsy. Pharmaceutics. 2020;12(3):203. doi: 10.3390/pharmaceutics12030203
   PubMed Web of Science ®Google Scholar
• Dhas N, Mehta T. Intranasal delivery of chitosan decorated PLGA core/shell nanoparticles containing flavonoid to reduce oxidative stress in the treatment of Alzheimer’s disease. J Drug Delivery Sci Technol. 2021;61:102242.
   Web of Science ®Google Scholar
• Moss DE. Improving anti-neurodegenerative benefits of acetylcholinesterase inhibitors in Alzheimer’s disease: are irreversible inhibitors the future? Int J Mol Sci. 2020;21(10):3438. doi: 10.3390/ijms21103438
   PubMed Web of Science ®Google Scholar
• Singh AK, Singh SS, Rathore AS, et al. Lipid-coated MCM-41 mesoporous silica nanoparticles loaded with berberine improved inhibition of acetylcholine esterase and amyloid formation. ACS Biomater Sci Eng. 2021;7(8):3737–3753. doi: 10.1021/acsbiomaterials.1c00514
   PubMed Web of Science ®Google Scholar
• Cole GM, Teter B, Frautschy SA. Neuroprotective effects of curcumin. The molecular targets and therapeutic uses of curcumin in health and disease. 2007:197–212.
   Google Scholar
• Mishra G, Awasthi R, Singh AK, et al. Intranasally Co-administered Berberine and curcumin loaded in transfersomal vesicles improved inhibition of amyloid formation and BACE-1. ACS Omega. 2022;7(47):43290–43305. doi: 10.1021/acsomega.2c06215
   PubMed Web of Science ®Google Scholar
• Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, evaluation, and treatment of coronavirus (COVID-19). 2020.
   Google Scholar
• Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.
   PubMed Web of Science ®Google Scholar
• Ghaebi M, Osali A, Valizadeh H, Roshangar L, Ahmadi M. Vaccine development and therapeutic design for 2019‐nCoV/SARS‐CoV‐2: Challenges and chances. Journal of cellular physiology. 2020;235(12):9098–109.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Conti PL, Di Iorio A, Guandalini A, Marella D, Vicard P, Vitale V. On the estimation of the Lorenz curve under complex sampling designs. Statistical Methods & Applications. 2020;29:1–24.
   Web of Science ®Google Scholar
• Kenny G, Mallon PW COVID19- clinical presentation and therapeutic considerations. Biochem Biophys Res Commun. 2021;538:125–131.10.1016/j.bbrc.2020.11.021
   PubMed Web of Science ®Google Scholar
• Afolayan FI, Erinwusi B, Oyeyemi OT. Immunomodulatory activity of curcumin-entrapped poly d, l-lactic-co-glycolic acid nanoparticles in mice. Integrative medicine research. 2018;7(2):168–75.
   PubMed Web of Science ®Google Scholar
• Trivedi MK, Mondal SC, Gangwar M, Jana S. Immunomodulatory potential of nanocurcumin-based formulation. Inflammopharmacology. 2017;25(6):609–619. doi: 10.1007/s10787-017-0395-3
   PubMed Web of Science ®Google Scholar
• Bar-On YM, Flamholz A, Phillips R, Milo R. SARS-CoV-2 (COVID-19) by the numbers. elife. 2020;9:e57309.10.7554/eLife.57309
   PubMed Web of Science ®Google Scholar
• Hassanzadeh K, Perez Pena H, Dragotto J, Buccarello L, Iorio F, Pieraccini S, et al. Considerations around the SARS-CoV-2 spike protein with particular attention to COVID-19 brain infection and neurological symptoms. ACS chemical neuroscience. 2020;11(15):2361–9.
   PubMed Web of Science ®Google Scholar
• Gunathilake TMSU, Ching YC, Uyama H, et al. Enhanced curcumin loaded nanocellulose: a possible inhalable nanotherapeutic to treat COVID-19. Cellul. 2022;29(3):1821–1840. doi: 10.1007/s10570-021-04391-8
   PubMed Web of Science ®Google Scholar
• Hanafy NAN, El-Kemary MA. Silymarin/Curcumin loaded albumin nanoparticles coated by chitosan as muco-inhalable delivery system observing anti-inflammatory and anti COVID-19 characterizations in oleic acid triggered lung injury and in vitro COVID-19 experiment. Int j biol macromol. 2022;198:101–110.
   PubMed Web of Science ®Google Scholar
• Zhang B, Swamy S, Balijepalli S, et al. Direct pulmonary delivery of solubilized curcumin reduces severity of lethal pneumonia. FASEB J. 2019;33(12):13294. doi: 10.1096/fj.201901047RR
   PubMed Web of Science ®Google Scholar
• Qin Y-Y, Zhou Y-H, Lu Y-Q, et al. Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial. Chinese med j. 2020;133(09):1080–1086. doi: 10.1097/CM9.0000000000000791
   PubMedGoogle Scholar
• Lechowicz K, Drożdżal S, Machaj F, et al. COVID-19: the potential treatment of pulmonary fibrosis associated with SARS-CoV-2 infection. J Clin Med. 2020;9(6):1917. doi: 10.3390/jcm9061917
   PubMed Web of Science ®Google Scholar
• Margaritopoulos GA, Vasarmidi E, Antoniou KM. Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy. Core evidence. 2016:11–22. Volume 11 10.2147/CE.S76549
   Google Scholar
• Wind S, Schmid U, Freiwald M, Marzin K, Lotz R, Ebner T, et al. Clinical pharmacokinetics and pharmacodynamics of nintedanib. Clinical pharmacokinetics. 2019;58:1131–47.
   PubMed Web of Science ®Google Scholar
• George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. The Lancet Respiratory Medicine. 2020;8(8):807–815. doi: 10.1016/S2213-2600(20)30225-3
   PubMed Web of Science ®Google Scholar
• Lüer S, Troller R, Aebi C. Antibacterial and antiinflammatory kinetics of curcumin as a potential antimucositis agent in cancer patients. Nutrition and cancer. 2012;64(7):975–981. doi: 10.1080/01635581.2012.713161
   PubMed Web of Science ®Google Scholar
• Rodwell C. Curcumin curries favour? Nat Rev Cancer. 2012;12(6):376-.
   Web of Science ®Google Scholar
• Roy B, Guha P, Bhattarai R, Nahak P, Karmakar G, Chettri P, et al. Influence of lipid composition, pH, and temperature on physicochemical properties of liposomes with curcumin as model drug. Journal of oleo science. 2016;65(5):399–411.
   PubMed Web of Science ®Google Scholar
• Hassanizadeh S, Shojaei M, Bagherniya M, et al. Effect of nano-curcumin on various diseases: a comprehensive review of clinical trials. BioFactors. 2023;49(3):512–533. doi: 10.1002/biof.1932
   PubMed Web of Science ®Google Scholar
• Mohammadi A, Yazdi SZ, Poursina Z, Hampson IN, Vakili V, Sahebkar A, et al. Nanomicellar Curcumin Supplementation Improves the Clinical Manifestations of HAM/TSP Patients. Adv Exp Med Biol. 13282021. p. 347–59.
   Google Scholar
• Shojaei M, Foshati S, Abdi M, et al. The effectiveness of nano-curcumin on patients with COVID-19: a systematic review of clinical trials. Phytother Res. 2023;37(4):1663–1677. doi: 10.1002/ptr.7778
   PubMed Web of Science ®Google Scholar
• Funamoto M, Sunagawa Y, Katanasaka Y, Miyazaki Y, Imaizumi A, Kakeya H, et al. Highly absorptive curcumin reduces serum atherosclerotic low-density lipoprotein levels in patients with mild COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2029–34.
   PubMed Web of Science ®Google Scholar
• Wauthoz N, Rosière R, Amighi K. Inhaled cytotoxic chemotherapy: clinical challenges, recent developments, and future prospects. Expert Opin Drug Delivery. 2021;18(3):333–354. doi: 10.1080/17425247.2021.1829590
   PubMed Web of Science ®Google Scholar
• Fuloria S, Mehta J, Chandel A, et al. A comprehensive review on the therapeutic potential of Curcuma longa Linn. in relation to its major active constituent curcumin. Front pharmacol. 2022;13:820806. 10.3389/fphar.2022.820806
   PubMed Web of Science ®Google Scholar
• Sandersen C, Bienzle D, Cerri S, Franck T, Derochette S, Neven P, et al. Effect of inhaled hydrosoluble curcumin on inflammatory markers in broncho-alveolar lavage fluid of horses with LPS-induced lung neutrophilia. Multidisciplinary Respiratory Medicine. 2015;10(1).
   PubMedGoogle Scholar
• Chen T, Zhuang B, Huang Y, et al. Inhaled curcumin mesoporous polydopamine nanoparticles against radiation pneumonitis. Acta Pharm Sin B. 2022;12(5):2522–2532. doi: 10.1016/j.apsb.2021.10.027.
   PubMed Web of Science ®Google Scholar
• McClure R, Yanagisawa D, Stec D, et al. Inhalable curcumin: offering the potential for translation to imaging and treatment of Alzheimer’s disease. J Alzheimers Dis. 2015;44(1):283–295. doi: 10.3233/JAD-140798.
   PubMed Web of Science ®Google Scholar